IHS Chemical Week

EnviroTech :: R&D

EU Trails U.S. on Biotech R&D Spending, Capability is Building

3:54 AM MDT | October 19, 2011 | Alex Scott

Europe needs to step up its investment in biotech R&D and establish supportive regulatory policies if it is to keep pace with the U.S. in the biotech sector, says Stephan Tanda, board member for DSM and chairman of industry biotech association EuropaBio. Total biotech R&D spending by publicly traded companies in the U.S. in 2009-2010 was $17.6 billion. This compares with €3.4 billion ($4.7 billion) in Europe during the same period. Tanda made his comments speaking earlier today at The European Forum for Industrial Biotechnology (EFIB) in Amsterdam...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa